{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:28:05Z","timestamp":1793212085779,"version":"4.5.0"},"reference-count":393,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2025,7,11]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background &amp; aims<\/jats:title>\n                    <jats:p>Pregnancy can be a complex and risk filled event for women with inflammatory bowel disease (IBD). High-quality studies in this population are lacking, with limited data on medications approved to treat IBD during pregnancy. For patients, limited knowledge surrounding pregnancy impacts pregnancy rates, medication adherence, and outcomes. Limited provider knowledge leads to highly varied practices in care affected by local dogma, available resources, individual interpretation of the literature, and fear of harming the fetus. The variations in guidelines by different societies and countries reflect this and lead to confusion for physicians and patients alike. The Global Consensus Consortium is a group of 39 IBD and content experts and 7 patient advocates from 6 continents who convened to review and assess current data and come to an agreement on best practices based on these data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The GRADE process was used when sufficient published data were available and the RAND process in those instances where expert opinion was needed to guide consistent practice. Recommendations were informed by the guiding principle that maternal health best supports infant health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The topics were divided into ten categories with 34 GRADE recommendations and 35 Consensus statements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, the goal of the group was to provide data-driven and practical guidance to improve the care of women with IBD around the globe based on the best available research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2025-336402","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T04:52:01Z","timestamp":1757393521000},"page":"208-251","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Global consensus statement on the management of pregnancy in inflammatory bowel disease"],"prefix":"10.1136","volume":"75","author":[{"given":"Uma","family":"Mahadevan","sequence":"first","affiliation":[{"name":"Gastroenterology, University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia H","family":"Seow","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L","family":"Barnes","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Chaparro","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, Hospital Universitario de La Princesa, Instituto de Investigaci\u00f3n Sanitaria Princesa (IIS-Princesa), Universidad Aut\u00f3noma de Madrid (UAM), and Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBEREHD), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Flanagan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St Vincent\u2019s Hospital Melbourne, Australia, Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Friedman","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Tufts Medical Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Julsgaard","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark, Institute of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunanda","family":"Kane","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew","family":"Ng","sequence":"additional","affiliation":[{"name":"Microbiota I-Center (MagIC), Hong Kong SAR, China, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China, Li Ka Shing Institute of Health Sciences, State Key Laboratory of Digestive Disease Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Torres","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hospital da Luz Lisbon, Division of Gastroenterology, Hospital Beatriz \u00c2ngelo, Portugal Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Watermeyer","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Yamamoto-Furusho","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Clinic, Department of Gastroenterology, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Robinson","sequence":"additional","affiliation":[{"name":"Charleston Maternal Fetal Medicine, East Cooper Medical Center, Mount Pleasant, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of California, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Anderson","sequence":"additional","affiliation":[{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gearry","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Otago, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Duricova","sequence":"additional","affiliation":[{"name":"Clinical and Research Center for IBD, ISCARE a s, Prague, Czechia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla","family":"Dubinsky","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology, Susan and Leonard Feinstein IBD Clinical Center, Icahn School of Medicine, Mount Sinai, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie","family":"Long","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"2026060303500874000_75.2.208.1","unstructured":"United States Food and Drug Administration . Final rule on the content and formation of a new drug application. 1998."},{"key":"2026060303500874000_75.2.208.2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1053\/j.gastro.2020.11.038","article-title":"Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease","volume":"160","author":"Mahadevan","year":"2021","journal-title":"Gastroenterology"},{"key":"2026060303500874000_75.2.208.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05130.x"},{"key":"2026060303500874000_75.2.208.4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jcag\/gwz036","article-title":"Pregnancy-Related Beliefs and Concerns of Inflammatory Bowel Disease Patients Modified After Accessing e-Health Portal","volume":"4","author":"Sutton","year":"2021","journal-title":"J Can Assoc Gastroenterol"},{"key":"2026060303500874000_75.2.208.5","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20082"},{"key":"2026060303500874000_75.2.208.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2009.10.001"},{"key":"2026060303500874000_75.2.208.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"2026060303500874000_75.2.208.8","unstructured":"FItch K , Bernstein SJ , Aguilar MD , et al . The RAND\/UCLA Appropriateness Method User\u2019s Manual. RAND 2001."},{"key":"2026060303500874000_75.2.208.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.015"},{"key":"2026060303500874000_75.2.208.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"2026060303500874000_75.2.208.11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cgh.2013.02.001","article-title":"The AGA institute process for developing clinical practice guidelines part one: grading the evidence","volume":"11","author":"Sultan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.12","unstructured":"PIANO . PIANO global consensus. Available: https:\/\/pianostudy.org\/conference.php [Accessed 10 Sep 2024]."},{"key":"2026060303500874000_75.2.208.13","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.50"},{"key":"2026060303500874000_75.2.208.14","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/MIB.0000000000001146","article-title":"The Association Between Maternal Chronic Inflammatory Bowel Disease and Long-term Health Outcomes in Children-A Nationwide Cohort Study","volume":"23","author":"J\u00f8lving","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01526.x"},{"key":"2026060303500874000_75.2.208.16","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.496"},{"key":"2026060303500874000_75.2.208.17","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.cgh.2020.09.054","article-title":"Familial Risk of Inflammatory Bowel Disease: A Population-Based Cohort Study in South Korea","volume":"19","author":"Kim","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/apt.16938","article-title":"Age determines the risk of familial inflammatory bowel disease-A nationwide study","volume":"56","author":"Halfvarson","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060303500874000_75.2.208.19","first-page":"2241","article-title":"Differences in risk of Crohn\u2019s disease in offspring of mothers and fathers with inflammatory bowel disease","volume":"92","author":"Akolkar","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"2026060303500874000_75.2.208.20","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2014.910834"},{"key":"2026060303500874000_75.2.208.21","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21805"},{"key":"2026060303500874000_75.2.208.22","doi-asserted-by":"publisher","DOI":"10.1038\/scientificamerican1017-46"},{"key":"2026060303500874000_75.2.208.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.08.042"},{"key":"2026060303500874000_75.2.208.24","first-page":"457","article-title":"Placental inflammation is not increased in inflammatory bowel disease","volume":"28","author":"Taleban","year":"2015","journal-title":"Ann Gastroenterol"},{"key":"2026060303500874000_75.2.208.25","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100884","article-title":"Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses","volume":"36","author":"Agrawal","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2026060303500874000_75.2.208.26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.reprotox.2021.05.005","article-title":"Maternal prenatal smoking and long-term gastrointestinal morbidity of the offspring: A population-based cohort analysis","volume":"103","author":"Karur","year":"2021","journal-title":"Reprod Toxicol"},{"key":"2026060303500874000_75.2.208.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.06.060"},{"key":"2026060303500874000_75.2.208.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142536","article-title":"Antepartum Antibiotic Treatment Increases Offspring Susceptibility to Experimental Colitis: A Role of the Gut Microbiota","volume":"10","author":"Munyaka","year":"2015","journal-title":"PLoS ONE"},{"key":"2026060303500874000_75.2.208.29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41564-017-0075-5","article-title":"Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice","volume":"3","author":"Schulfer","year":"2018","journal-title":"Nat Microbiol"},{"key":"2026060303500874000_75.2.208.30","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuw0613063254"},{"key":"2026060303500874000_75.2.208.31","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314352"},{"key":"2026060303500874000_75.2.208.32","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327724"},{"key":"2026060303500874000_75.2.208.33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ecco-jcc\/jjac111","article-title":"Risk Factors for Developing Inflammatory Bowel Disease Within and Across Families with a Family History of IBD","volume":"17","author":"Torres","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2014.08.009"},{"key":"2026060303500874000_75.2.208.35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002507","article-title":"Diet during pregnancy and infancy and risk of allergic or autoimmune disease: A systematic review and meta-analysis","volume":"15","author":"Garcia-Larsen","year":"2018","journal-title":"PLoS Med"},{"key":"2026060303500874000_75.2.208.36","first-page":"S","article-title":"962 EARLY LIFE EXPOSURE TO PARENTAL CROHN\u2019S DISEASE IS ASSOCIATED WITH ALTERED GUT MICROBIOME COMPOSITION, IMPAIRED GUT PERMEABILITY, AND INCREASED RISK OF INCIDENT CROHN\u2019S DISEASE","volume":"164","author":"Lee","year":"2023","journal-title":"Gastroenterology"},{"key":"2026060303500874000_75.2.208.37","doi-asserted-by":"publisher","DOI":"10.3109\/00365528708991950"},{"key":"2026060303500874000_75.2.208.38","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-020-1182-y","article-title":"Intake of dairy protein during pregnancy in IBD and risk of SGA in a Norwegian population-based mother and child cohort","volume":"20","author":"Bengtson","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"2026060303500874000_75.2.208.39","first-page":"S","article-title":"659 IMPACT OF MATERNAL FOOD ADDITIVE ON GUT MICROBIOME AND VERTICAL BACTERIA STRAIN SHARING BETWEEN WOMEN WITH IBD AND THEIR INFANTS (MOMMY-IBD STUDY)","volume":"166","author":"Zhang","year":"2024","journal-title":"Gastroenterology"},{"key":"2026060303500874000_75.2.208.40","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1649"},{"key":"2026060303500874000_75.2.208.41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41575-023-00864-2","article-title":"The maternal gut microbiome in pregnancy: implications for the developing immune system","volume":"21","author":"Koren","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.07.008"},{"key":"2026060303500874000_75.2.208.43","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317855"},{"key":"2026060303500874000_75.2.208.44","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(24)01739-6","article-title":"Altered faecal and breastmilk microbiome and vertical bacteria strain sharing between pregnant women with inflammatory bowel disease and their infants (MOMMY-IBD)","volume":"166","author":"Tun","year":"2024","journal-title":"Gastroenterology"},{"key":"2026060303500874000_75.2.208.45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1096\/fba.2021-00078","article-title":"Maternal Lactobacillus reuteri supplementation shifts the intestinal microbiome in mice and provides protection from experimental colitis in female offspring","volume":"4","author":"Krishna","year":"2022","journal-title":"FASEB Bioadv"},{"key":"2026060303500874000_75.2.208.46","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2020.100573","article-title":"A dietary intervention to improve the microbiome composition of pregnant women with Crohn\u2019s disease and their offspring: The MELODY (Modulating Early Life Microbiome through Dietary Intervention in Pregnancy) trial design","volume":"18","author":"Peter","year":"2020","journal-title":"Contemp Clin Trials Commun"},{"key":"2026060303500874000_75.2.208.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.06.005"},{"key":"2026060303500874000_75.2.208.48","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/ecco-jcc\/jjac170","article-title":"Fertility and Assisted Reproductive Technologies Outcomes of Women with Non-surgically Managed Inflammatory Bowel Diseases: A Systematic Review","volume":"17","author":"Vieujean","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/ecco-jcc\/jjaa191","article-title":"Impaired Fertility in Women With Inflammatory Bowel Disease: A National Cohort Study From Sweden","volume":"15","author":"Druvefors","year":"2021","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/jcag\/gwac003","article-title":"Pregnancy and Live Birth Rates Over Time in Women With Inflammatory Bowel Disease: A Population-Based Cohort Study","volume":"5","author":"Tandon","year":"2022","journal-title":"J Can Assoc Gastroenterol"},{"key":"2026060303500874000_75.2.208.51","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/codi.16123","article-title":"The impact of the ileoanal pouch on female fertility in ulcerative colitis: A systematic review and meta-analysis","volume":"24","author":"Sriranganathan","year":"2022","journal-title":"Colorectal Dis"},{"key":"2026060303500874000_75.2.208.52","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-011-1274-9"},{"key":"2026060303500874000_75.2.208.53","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.090316"},{"key":"2026060303500874000_75.2.208.54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jcag\/gwaa010","article-title":"Surgery for Inflammatory Bowel Disease Has Unclear Impact on Female Fertility: A Cochrane Collaboration Systematic Review","volume":"4","author":"Lee","year":"2021","journal-title":"J Can Assoc Gastroenterol"},{"key":"2026060303500874000_75.2.208.55","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/ecco-jcc\/jjad079","article-title":"Female and Male Fertility after Colectomy and Reconstructive Surgery in Inflammatory Bowel Diesase: A National Cohort Study from Sweden","volume":"17","author":"Druvefors","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.56","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318250caa9"},{"key":"2026060303500874000_75.2.208.57","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.surg.2019.04.045","article-title":"Does laparoscopic ileal pouch-anal anastomosis reduce infertility compared with open approach?","volume":"166","author":"Gorgun","year":"2019","journal-title":"Surgery"},{"key":"2026060303500874000_75.2.208.58","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13354"},{"key":"2026060303500874000_75.2.208.59","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/apt.15654","article-title":"Pregnancy outcomes in women with inflammatory bowel disease: a 10-year nationwide population-based cohort study","volume":"51","author":"Lee","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060303500874000_75.2.208.60","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/j.gastro.2024.01.018","article-title":"Histologic Remission in Inflammatory Bowel Disease and Female Fertility: A Nationwide Study","volume":"166","author":"M\u00e5rild","year":"2024","journal-title":"Gastroenterology"},{"key":"2026060303500874000_75.2.208.61","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101517","article-title":"Ovarian reserve and IVF outcomes in patients with inflammatory bowel disease: A systematic review and meta-analysis","volume":"50","author":"Sun","year":"2022","journal-title":"EClinicalMedicine"},{"key":"2026060303500874000_75.2.208.62","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/09513590.2019.1684465","article-title":"Infertile patients with inflammatory bowel disease have comparable in vitro fertilization clinical outcomes to the general infertile population","volume":"36","author":"Hernandez-Nieto","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"2026060303500874000_75.2.208.63","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MIB.0000000000000996","article-title":"The Efficacy of Assisted Reproduction in Women with Inflammatory Bowel Disease and the Impact of Surgery\u2014A Nationwide Cohort Study","volume":"23","author":"Friedman","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.03.016"},{"key":"2026060303500874000_75.2.208.65","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311246"},{"key":"2026060303500874000_75.2.208.66","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.14309\/ajg.0000000000001537","article-title":"Assisted Reproductive Technology in Crohn\u2019s Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis","volume":"116","author":"Laube","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"2026060303500874000_75.2.208.67","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.400"},{"key":"2026060303500874000_75.2.208.68","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/DCR.0000000000001640","article-title":"Impact on Fertility After Failure of Restorative Proctocolectomy in Men and Women With Ulcerative Colitis: A 17-Year Cohort Study","volume":"63","author":"Pachler","year":"2020","journal-title":"Dis Colon Rectum"},{"key":"2026060303500874000_75.2.208.69","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/ecco-jcc\/jjz055","article-title":"Use and Success of In Vitro Fertilisation Following Restorative Proctocolectomy and Ileal Pouch-anal Anastomosis. A Nationwide 17-year Cohort Study","volume":"13","author":"Pachler","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.70","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-311805"},{"key":"2026060303500874000_75.2.208.71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/jog.15818","article-title":"from the subcommittee \u201cSurvey of AMH measurement in Japan\u201d in Reproductive Endocrinology Committee; Japan Society of Obstetrics and Gynecology","volume":"50","author":"Iwase","year":"2024","journal-title":"J Obstet Gynaecol Res"},{"key":"2026060303500874000_75.2.208.72","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21872"},{"key":"2026060303500874000_75.2.208.73","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-023-01112-6","article-title":"Clinical characteristics and risk factors of ovarian reserve decreases in women with Crohn\u2019s disease: a case-control study","volume":"16","author":"Xiang","year":"2023","journal-title":"J Ovarian Res"},{"key":"2026060303500874000_75.2.208.74","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5217\/ir.2019.00103","article-title":"Risk Factors Associated with Impaired Ovarian Reserve in Young Women of Reproductive Age with Crohn\u2019s Disease","volume":"18","author":"Zhao","year":"2020","journal-title":"Intest Res"},{"key":"2026060303500874000_75.2.208.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.03.003"},{"key":"2026060303500874000_75.2.208.76","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.33549\/physiolres.934776","article-title":"Ovarian Reserve Assessed by the Anti-Mullerian Hormone and Reproductive Health Parameters in Women With Crohn's Disease, a Case-Control Study","volume":"70","author":"Koller","year":"2021","journal-title":"Physiol Res"},{"key":"2026060303500874000_75.2.208.77","article-title":"Inflammatory bowel disease can reduce ovarian reserve function in women: A systematic review and meta-analysis","volume":"102","author":"Guo","year":"2023","journal-title":"Medicine (Abingdon)"},{"key":"2026060303500874000_75.2.208.78","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.fertnstert.2021.07.1198","article-title":"The impact of medical therapies and factors related to treatment procedures in women with rheumatoid arthritis and inflammatory bowel disease receiving assisted reproduction: a nationwide cohort study","volume":"116","author":"N\u00f8rg\u00e5rd","year":"2021","journal-title":"Fertil Steril"},{"key":"2026060303500874000_75.2.208.79","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjac115"},{"key":"2026060303500874000_75.2.208.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.07.009"},{"key":"2026060303500874000_75.2.208.81","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/cts.13068","article-title":"Persistent follicular granulosa cell senescence and apoptosis induced by methotrexate leading to oocyte dysfunction and aberrant embryo development","volume":"14","author":"Fu","year":"2021","journal-title":"Clin Transl Sci"},{"key":"2026060303500874000_75.2.208.82","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10815-016-0683-7","article-title":"Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes","volume":"33","author":"Boots","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"2026060303500874000_75.2.208.83","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/CLEP.S234996","article-title":"Corticosteroids Prior to Embryo Transfer in Assisted Reproduction in Women with Crohn\u2019s Disease and Ulcerative Colitis - A Nationwide Cohort Study","volume":"12","author":"N\u00f8rg\u00e5rd","year":"2020","journal-title":"Clin Epidemiol"},{"key":"2026060303500874000_75.2.208.84","doi-asserted-by":"crossref","first-page":"2227310","DOI":"10.1080\/14767058.2023.2227310","article-title":"Glucocorticoid supplementation during ovulation induction for assisted reproductive technology: a systematic review and meta-analysis","volume":"36","author":"Lin","year":"2023","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2026060303500874000_75.2.208.85","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40263-023-01036-1","article-title":"Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis","volume":"37","author":"Sparaco","year":"2023","journal-title":"CNS Drugs"},{"key":"2026060303500874000_75.2.208.86","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/ibd\/izab021","article-title":"A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive","volume":"27","author":"Flanagan","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.87","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jgh3.12442","article-title":"Addressing pregnancy-related concerns in women with inflammatory bowel disease: Insights from the patient\u2019s perspective","volume":"5","author":"Flanagan","year":"2021","journal-title":"JGH Open"},{"key":"2026060303500874000_75.2.208.88","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw078"},{"key":"2026060303500874000_75.2.208.89","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/ecco-jcc\/jjaa047","article-title":"Knowledge and Attitudes Towards Pregnancy in Females with Inflammatory Bowel Disease: An International, Multi-centre Study","volume":"14","author":"Laube","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.90","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/j.crohns.2012.09.010","article-title":"Inflammatory bowel disease and pregnancy: Lack of knowledge is associated with negative views","volume":"7","author":"Selinger","year":"2013","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"2026060303500874000_75.2.208.91","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw052"},{"key":"2026060303500874000_75.2.208.92","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21522"},{"key":"2026060303500874000_75.2.208.93","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04318.x"},{"key":"2026060303500874000_75.2.208.94","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.cgh.2016.03.018","article-title":"Preconception Care Reduces Relapse of Inflammatory Bowel Disease During Pregnancy","volume":"14","author":"de Lima","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.95","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1007\/s10620-022-07494-9","article-title":"A Novel Decision Aid Improves Quality of Reproductive Decision-Making and Pregnancy Knowledge for Women with Inflammatory Bowel Disease","volume":"67","author":"Wang","year":"2022","journal-title":"Dig Dis Sci"},{"key":"2026060303500874000_75.2.208.96","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1093\/ibd\/izy161","article-title":"Innovative Online Educational Portal Improves Disease-Specific Reproductive Knowledge Among Patients With Inflammatory Bowel Disease","volume":"24","author":"Wierstra","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.97","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1007\/s10620-021-06998-0","article-title":"A Dedicated Pregnancy Clinic Improves Reproductive Knowledge in Inflammatory Bowel Disease","volume":"67","author":"Jogendran","year":"2022","journal-title":"Dig Dis Sci"},{"key":"2026060303500874000_75.2.208.98","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/ibd\/izad147","article-title":"Despite Increased Disease Activity, Women who Attended a Dedicated Inflammatory Bowel Disease and Pregnancy Clinic Had Infants With Higher Apgar Scores: A Population-Based Study","volume":"30","author":"Lee","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.99","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s10620-018-5048-x","article-title":"Antenatal Management for Women with Inflammatory Bowel Disease: Experience from Our \u201cIBD MOM\u201d Clinic","volume":"63","author":"Shitrit","year":"2018","journal-title":"Dig Dis Sci"},{"key":"2026060303500874000_75.2.208.100","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s10620-020-06480-3","article-title":"Identifying Patient Priorities for Preconception and Pregnancy Counseling in IBD","volume":"66","author":"Aboubakr","year":"2021","journal-title":"Dig Dis Sci"},{"key":"2026060303500874000_75.2.208.101","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.fertnstert.2018.12.003","article-title":"Prepregnancy counseling: committee opinion no.762","volume":"111","year":"2019","journal-title":"Fertil Steril"},{"key":"2026060303500874000_75.2.208.102","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12417"},{"key":"2026060303500874000_75.2.208.103","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/apt.17348","article-title":"Predictors of disease activity during pregnancy in women with inflammatory bowel disease\u2014a Danish cohort study","volume":"57","author":"Vestergaard","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060303500874000_75.2.208.104","first-page":"101","article-title":"Fertility and Contraception in Women With Inflammatory Bowel Disease","volume":"12","author":"Martin","year":"2016","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"2026060303500874000_75.2.208.105","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.02.012"},{"key":"2026060303500874000_75.2.208.106","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/j.gastro.2016.02.041","article-title":"Association Between Long-term Oral Contraceptive Use and Risk of Crohn\u2019s Disease Complications in a Nationwide Study","volume":"150","author":"Khalili","year":"2016","journal-title":"Gastroenterology"},{"key":"2026060303500874000_75.2.208.107","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.amsu.2015.10.020","article-title":"Hormonal contraceptives and venous thromboembolism: Are inflammatory bowel disease patients at increased risk? A retrospective study on a prospective database","volume":"4","author":"Pellino","year":"2015","journal-title":"Annals of Medicine & Surgery"},{"key":"2026060303500874000_75.2.208.108","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2010.033"},{"key":"2026060303500874000_75.2.208.109","article-title":"Trends in Faecal Calprotectin Levels During Pregnancy in Non-IBD Patients","volume":"115","author":"Doherty","year":"2022","journal-title":"Ir Med J"},{"key":"2026060303500874000_75.2.208.110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejim.2020.03.015","article-title":"Clinical utility of fecal calprotectin in monitoring disease activity and predicting relapse in pregnant patients with inflammatory bowel diseases","volume":"77","author":"Rottenstreich","year":"2020","journal-title":"Eur J Intern Med"},{"key":"2026060303500874000_75.2.208.111","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MCG.0000000000001244","article-title":"Noninvasive Methods For Assessing Inflammatory Bowel Disease Activity in Pregnancy: A Systematic Review","volume":"53","author":"Tandon","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"2026060303500874000_75.2.208.112","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/ibd\/izx055","article-title":"Fecal Calprotectin During Pregnancy in Women With Moderate-Severe Inflammatory Bowel Disease","volume":"24","author":"Kammerlander","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.113","doi-asserted-by":"publisher","DOI":"10.1177\/08465371211015657"},{"key":"2026060303500874000_75.2.208.114","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ecco-jcc\/jjaa082","article-title":"Monitoring Inflammatory Bowel Disease in Pregnancy Using Gastrointestinal Ultrasonography","volume":"14","author":"Flanagan","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.115","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/ibd\/izab216","article-title":"Intestinal Ultrasound to Evaluate Treatment Response During Pregnancy in Patients With Inflammatory Bowel Disease","volume":"28","author":"De Voogd","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.116","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2012.02.029"},{"key":"2026060303500874000_75.2.208.117","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12876-015-0244-z","article-title":"Does lower gastrointestinal endoscopy during pregnancy pose a risk for mother and child? \u2013 a systematic review","volume":"15","author":"De Lima","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"2026060303500874000_75.2.208.118","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s10620-020-06122-8","article-title":"Safety of Flexible Sigmoidoscopy in Pregnant Patients with Known or Suspected Inflammatory Bowel Disease","volume":"65","author":"Ko","year":"2020","journal-title":"Dig Dis Sci"},{"key":"2026060303500874000_75.2.208.119","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/ecco-jcc\/jjac050","article-title":"Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study]","volume":"16","author":"Chaparro","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.120","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1177\/2050640620921060","article-title":"Surgery for Crohn\u2019s disease during pregnancy: A nationwide survey","volume":"8","author":"Germain","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"2026060303500874000_75.2.208.121","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/aogs.13775","article-title":"Non-obstetric abdominal surgery during pregnancy and birth outcomes: A Danish registry-based cohort study","volume":"99","author":"Rasmussen","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2026060303500874000_75.2.208.122","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/codi.13413","article-title":"Surgical management of complicated and medically refractory inflammatory bowel disease during pregnancy","volume":"19","author":"Killeen","year":"2017","journal-title":"Colorectal Dis"},{"key":"2026060303500874000_75.2.208.123","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00384-022-04185-9","article-title":"A national study of pregnancy-related maternal and fetal outcomes in women with inflammatory bowel disease","volume":"37","author":"Tarar","year":"2022","journal-title":"Int J Colorectal Dis"},{"key":"2026060303500874000_75.2.208.124","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12884-015-0452-0","article-title":"Contribution of prepregnancy body mass index and gestational weight gain to adverse neonatal outcomes: population attributable fractions for Canada","volume":"15","author":"Dzakpasu","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"2026060303500874000_75.2.208.125","first-page":"2881","article-title":"Inadequate gestational weight gain and adverse pregnancy outcomes among normal weight women in China","volume":"8","author":"Wen","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"2026060303500874000_75.2.208.126","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2012.684176"},{"key":"2026060303500874000_75.2.208.127","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/MIB.0000000000001123","article-title":"Inadequate Gestational Weight Gain, the Hidden Link Between Maternal IBD and Adverse Pregnancy Outcomes: Results from the Norwegian Mother and Child Cohort Study","volume":"23","author":"Bengtson","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.128","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/apt.15587","article-title":"Systematic review with meta-analysis: risk of adverse pregnancy-related outcomes in inflammatory bowel disease","volume":"51","author":"Tandon","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060303500874000_75.2.208.129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129567","article-title":"Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes","volume":"10","author":"Boyd","year":"2015","journal-title":"PLoS One"},{"key":"2026060303500874000_75.2.208.130","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/jth.13638","article-title":"Inflammatory bowel disease and venous thromboembolism during pregnancy and the postpartum period","volume":"15","author":"Hansen","year":"2017","journal-title":"J Thromb Haemost"},{"key":"2026060303500874000_75.2.208.131","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f3443","article-title":"Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis","volume":"346","author":"Haider","year":"2013","journal-title":"BMJ"},{"key":"2026060303500874000_75.2.208.132","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000472"},{"key":"2026060303500874000_75.2.208.133","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"2026060303500874000_75.2.208.134","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/ibd\/izad250","article-title":"Longitudinal Trends in Pregnancy Outcomes Among Women With Inflammatory Bowel Disease in the Era of Biologics: A 20-Year Nationwide Analysis","volume":"30","author":"Prakash","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.135","doi-asserted-by":"publisher","DOI":"10.1080\/14767050410001668662"},{"key":"2026060303500874000_75.2.208.136","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.02.014"},{"key":"2026060303500874000_75.2.208.137","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.14781"},{"key":"2026060303500874000_75.2.208.138","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2026060303500874000_75.2.208.139","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2023.04.023"},{"key":"2026060303500874000_75.2.208.140","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704559"},{"key":"2026060303500874000_75.2.208.141","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.11.561"},{"key":"2026060303500874000_75.2.208.142","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejogrb.2022.12.032","article-title":"Clinical practice guidelines on the use of aspirin in pregnancy: Systematic review","volume":"282","author":"Di Girolamo","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026060303500874000_75.2.208.143","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.15.1168"},{"key":"2026060303500874000_75.2.208.144","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/ibd\/izaa060","article-title":"Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease","volume":"27","author":"Patel","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.145","doi-asserted-by":"crossref","unstructured":"Memel Z , Yu A , Fenton C , et al . The Effect of Low-Dose Aspirin on Disease Activity in Pregnant Individuals With Inflammatory Bowel Disease. Am J Gastroenterol 2025. doi:10.14309\/ajg.0000000000003304","DOI":"10.14309\/ajg.0000000000003304"},{"key":"2026060303500874000_75.2.208.146","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-024-08364-2"},{"key":"2026060303500874000_75.2.208.147","doi-asserted-by":"crossref","unstructured":"Day AS , Yao CK , Costello SP , et al . Food avoidance, restrictive eating behaviour and association with quality of life in adults with inflammatory bowel disease: A systematic scoping review. Appetite 2021;167. doi:10.1016\/j.appet.2021.105650","DOI":"10.1016\/j.appet.2021.105650"},{"key":"2026060303500874000_75.2.208.148","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20429"},{"key":"2026060303500874000_75.2.208.149","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jju009"},{"key":"2026060303500874000_75.2.208.150","doi-asserted-by":"crossref","first-page":"619176","DOI":"10.3389\/fendo.2021.619176","article-title":"Maternal Vitamin B12 Status During Pregnancy and Its Association With Outcomes of Pregnancy and Health of the Offspring: A Systematic Review and Implications for Policy in India","volume":"12","author":"Behere","year":"2021","journal-title":"Front Endocrinol"},{"key":"2026060303500874000_75.2.208.151","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ejcn.2016.12","article-title":"Hypovitaminosis D in pregnancy in the Mediterranean region: a systematic review","volume":"70","author":"Karras","year":"2016","journal-title":"Eur J Clin Nutr"},{"key":"2026060303500874000_75.2.208.152","doi-asserted-by":"crossref","DOI":"10.3390\/nu14091900","article-title":"Vitamin D: Before, during and after Pregnancy: Effect on Neonates and Children","volume":"14","author":"Mansur","year":"2022","journal-title":"Nutrients"},{"key":"2026060303500874000_75.2.208.153","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/OGX.0000000000000836","article-title":"Nutrition in Pregnancy: A Comparative Review of Major Guidelines","volume":"75","author":"Tsakiridis","year":"2020","journal-title":"Obstet Gynecol Surv"},{"key":"2026060303500874000_75.2.208.154","unstructured":"World Health Organization . WHO recommendation on daily oral iron and folic acid supplementation. Geneva: World Health Organization, 2016."},{"key":"2026060303500874000_75.2.208.155","doi-asserted-by":"crossref","DOI":"10.1186\/s12978-018-0536-1","article-title":"Commentary: Iron deficiency of pregnancy - a new approach involving intravenous iron","volume":"15","author":"Auerbach","year":"2018","journal-title":"Reprod Health"},{"key":"2026060303500874000_75.2.208.156","unstructured":"Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines . Weight gain during pregnancy: reexamining the guidelines. National Academies Press, 2010."},{"key":"2026060303500874000_75.2.208.157","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-329304"},{"key":"2026060303500874000_75.2.208.158","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01537.x"},{"key":"2026060303500874000_75.2.208.159","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/MIB.0000000000001112","article-title":"Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review","volume":"23","author":"Foulon","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.160","doi-asserted-by":"crossref","DOI":"10.1016\/j.xagr.2024.100333","article-title":"Vaginal delivery in women with perianal Crohn\u2019s disease: why not?","volume":"4","author":"Schaafsma","year":"2024","journal-title":"AJOG Glob Rep"},{"key":"2026060303500874000_75.2.208.161","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0b013e3182a41381"},{"key":"2026060303500874000_75.2.208.162","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.dld.2015.08.001","article-title":"Perianal Crohn\u2019s disease results in fewer pregnancies but is not exacerbated by vaginal delivery","volume":"47","author":"Grouin","year":"2015","journal-title":"Dig Liver Dis"},{"key":"2026060303500874000_75.2.208.163","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000093"},{"key":"2026060303500874000_75.2.208.164","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-023-03018-5","article-title":"The mode of delivery does not influence the occurrence of post-partum perianal disease flares in patients with inflammatory bowel disease","volume":"24","author":"Otero-Pi\u00f1erio","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"2026060303500874000_75.2.208.165","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/tmi.12771","article-title":"Pregnancy and childbirth after repair of obstetric fistula in sub-Saharan Africa: Scoping Review","volume":"21","author":"Delamou","year":"2016","journal-title":"Trop Med Int Health"},{"key":"2026060303500874000_75.2.208.166","doi-asserted-by":"crossref","first-page":"e1152","DOI":"10.1016\/S2214-109X(17)30366-2","article-title":"Fistula recurrence, pregnancy, and childbirth following successful closure of female genital fistula in Guinea: a longitudinal study","volume":"5","author":"Delamou","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2026060303500874000_75.2.208.167","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-004-0569-0"},{"key":"2026060303500874000_75.2.208.168","doi-asserted-by":"publisher","DOI":"10.1007\/BF02052444"},{"key":"2026060303500874000_75.2.208.169","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200006000-00017"},{"key":"2026060303500874000_75.2.208.170","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-004-6411-x"},{"key":"2026060303500874000_75.2.208.171","doi-asserted-by":"publisher","DOI":"10.1007\/BF00342465"},{"key":"2026060303500874000_75.2.208.172","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3109\/14767058.2010.494745","article-title":"Pouch function and gastrointestinal complications during pregnancy after ileal pouch-anal anastomosis","volume":"24","author":"Seligman","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2026060303500874000_75.2.208.173","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-005-0124-7"},{"key":"2026060303500874000_75.2.208.174","doi-asserted-by":"crossref","first-page":"419","DOI":"10.23922\/jarc.2021-022","article-title":"Delivery Mode after Ileal Pouch-Anal Anastomosis among Pregnant Women with Ulcerative Colitis","volume":"5","author":"Goto","year":"2021","journal-title":"J Anus Rectum Colon"},{"key":"2026060303500874000_75.2.208.175","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.5467"},{"key":"2026060303500874000_75.2.208.176","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/S0264-410X(03)00334-7","article-title":"Placental transport of immunoglobulin G","volume":"21","author":"Simister","year":"2003","journal-title":"Vaccine (Auckl)"},{"key":"2026060303500874000_75.2.208.177","doi-asserted-by":"publisher","DOI":"10.3109\/00016349409006251"},{"key":"2026060303500874000_75.2.208.178","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ibd\/izaa122","article-title":"The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","volume":"27","author":"Leung","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.179","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.09.061"},{"key":"2026060303500874000_75.2.208.180","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01216.x"},{"key":"2026060303500874000_75.2.208.181","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2007.11.010"},{"key":"2026060303500874000_75.2.208.182","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70628-6"},{"key":"2026060303500874000_75.2.208.183","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.2.243"},{"key":"2026060303500874000_75.2.208.184","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.04140.x"},{"key":"2026060303500874000_75.2.208.185","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/apt.17189","article-title":"The safety of paternal and maternal use of 5-aminosalicylic acid during conception and pregnancy: a nationwide cohort study","volume":"56","author":"N\u00f8rg\u00e5rd","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060303500874000_75.2.208.186","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3109\/00365521.2013.879734","article-title":"Maternal use of 5-aminosalicylates in early pregnancy and congenital malformation risk in the offspring","volume":"49","author":"K\u00e4ll\u00e9n","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"2026060303500874000_75.2.208.187","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.3748\/wjg.v19.i41.7042","article-title":"Presence of phthalates in gastrointestinal medications: is there a hidden danger?","volume":"19","author":"Gallinger","year":"2013","journal-title":"World J Gastroenterol"},{"key":"2026060303500874000_75.2.208.188","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10620-020-06221-6","article-title":"Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes","volume":"66","author":"Watanabe","year":"2021","journal-title":"Dig Dis Sci"},{"key":"2026060303500874000_75.2.208.189","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/apt.15596","article-title":"Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications","volume":"51","author":"Lee","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060303500874000_75.2.208.190","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225080-00003"},{"key":"2026060303500874000_75.2.208.191","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-6-210","article-title":"Importance of appropriate pharmaceutical management in pregnant women with ulcerative colitis","volume":"6","author":"Ujihara","year":"2013","journal-title":"BMC Res Notes"},{"key":"2026060303500874000_75.2.208.192","doi-asserted-by":"crossref","first-page":"104580","DOI":"10.1016\/j.envint.2019.02.003","article-title":"Phthalate exposure and female reproductive and developmental outcomes: a systematic review of the human epidemiological evidence","volume":"130","author":"Radke","year":"2019","journal-title":"Environ Int"},{"key":"2026060303500874000_75.2.208.193","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.reprotox.2016.04.007","article-title":"Maternal exposure to di-n-butyl phthalate (DBP) induces combined anorectal and urogenital malformations in male rat offspring","volume":"61","author":"Zhu","year":"2016","journal-title":"Reprod Toxicol"},{"key":"2026060303500874000_75.2.208.194","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.060103"},{"key":"2026060303500874000_75.2.208.195","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.15389"},{"key":"2026060303500874000_75.2.208.196","first-page":"2201","article-title":"Safety of topical 5-aminosalicylic acid in pregnancy","volume":"92","author":"Bell","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"2026060303500874000_75.2.208.197","doi-asserted-by":"publisher","DOI":"10.3109\/00365528109182032"},{"key":"2026060303500874000_75.2.208.198","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1987.tb10430.x"},{"key":"2026060303500874000_75.2.208.199","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00962.x"},{"key":"2026060303500874000_75.2.208.200","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2011.626442"},{"key":"2026060303500874000_75.2.208.201","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z"},{"key":"2026060303500874000_75.2.208.202","unstructured":"Heinonen OP , Slone D , Shapiro S . Birth defects and drug in pregnancy. Publishing Sciences Group, 1977:299\u2013302."},{"key":"2026060303500874000_75.2.208.203","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv006"},{"key":"2026060303500874000_75.2.208.204","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325317"},{"key":"2026060303500874000_75.2.208.205","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-023-02817-7","article-title":"Adverse birth outcomes and early-life infections after in utero exposure to corticosteroids for inflammatory bowel disease: a Danish nationwide cohort study","volume":"21","author":"J\u00f8lving","year":"2023","journal-title":"BMC Med"},{"key":"2026060303500874000_75.2.208.206","article-title":"Oral budesonide for induction of remission in ulcerative colitis","volume":"2015","author":"Sherlock","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026060303500874000_75.2.208.207","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1080\/00365521.2018.1533583","article-title":"Pregnancy outcome in four women with inflammatory bowel disease treated with budesonide MMX","volume":"53","author":"Vestergaard","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"2026060303500874000_75.2.208.208","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20640"},{"key":"2026060303500874000_75.2.208.209","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/apt.17666","article-title":"Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitis","volume":"58","author":"Aruljothy","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060303500874000_75.2.208.210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.reprotox.2019.05.066","article-title":"Fetal methotrexate syndrome: A systematic review of case reports","volume":"87","author":"Verberne","year":"2019","journal-title":"Reprod Toxicol"},{"key":"2026060303500874000_75.2.208.211","first-page":"678","article-title":"Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding)","volume":"27","author":"Mart\u00ednez Lopez","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"2026060303500874000_75.2.208.212","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.38368","article-title":"Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study","volume":"66","author":"Weber-Schoendorfer","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026060303500874000_75.2.208.213","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/ajmg.a.36625","article-title":"National Birth Defects Prevention Study. Maternal exposure to methotrexate and birth defects: a population-based study","volume":"164A","author":"Dawson","year":"2014","journal-title":"Am J Med Genet A"},{"key":"2026060303500874000_75.2.208.214","first-page":"2360","article-title":"French Network of Regional Pharmacovigilance Centers. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study","volume":"31","author":"Lewden","year":"2004","journal-title":"J Rheumatol"},{"key":"2026060303500874000_75.2.208.215","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011303432204"},{"key":"2026060303500874000_75.2.208.216","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319129"},{"key":"2026060303500874000_75.2.208.217","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/apt.16578","article-title":"The risk of chronic diseases and congenital malformations during childhood and adolescence after in utero exposure to thiopurines","volume":"54","author":"J\u00f8lving","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060303500874000_75.2.208.218","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.01.009"},{"key":"2026060303500874000_75.2.208.219","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cgh.2021.07.028","article-title":"Serious Infections in Children Born to Mothers With Inflammatory Bowel Disease With In Utero Exposure to Thiopurines and Anti-Tumor Necrosis Factor","volume":"20","author":"Meyer","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.220","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/ecco-jcc\/jjae023","article-title":"Thiopurine Metabolite Shunting in Late Pregnancy Increases the Risk of Intrahepatic Cholestasis of Pregnancy in Women With Inflammatory Bowel Disease, and Can be Managed With Split Dosing","volume":"18","author":"Prentice","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.221","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303615"},{"key":"2026060303500874000_75.2.208.222","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/apt.16294","article-title":"Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates","volume":"53","author":"Flanagan","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060303500874000_75.2.208.223","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/14740338.2023.2234813","article-title":"Antenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancy","volume":"22","author":"Selinger","year":"2023","journal-title":"Expert Opin Drug Saf"},{"key":"2026060303500874000_75.2.208.224","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/apt.18126","article-title":"Multicentre study and systematic review: Allopurinol exposure during pregnancy","volume":"60","author":"Crouwel","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060303500874000_75.2.208.225","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.reprotox.2018.08.012","article-title":"The teratogenicity of allopurinol: A comprehensive review of animal and human studies","volume":"81","author":"Simsek","year":"2018","journal-title":"Reprod Toxicol"},{"key":"2026060303500874000_75.2.208.226","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ecco-jcc\/jjac183","article-title":"Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease","volume":"17","author":"Crouwel","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.227","doi-asserted-by":"crossref","DOI":"10.1093\/crocol\/otad066","article-title":"Thiopurine Exposure During Pregnancy is Not Associated With Anemia in Infants Born to Mothers With IBD","volume":"5","author":"Yeaman","year":"2023","journal-title":"Crohn\u2019s & Colitis 360"},{"key":"2026060303500874000_75.2.208.228","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1093\/ibd\/izae008","article-title":"Thrombocytosis and Transaminitis in Infants Born to Women With Inflammatory Bowel Disease Is Associated With Exposure to Maternal Inflammation In Utero","volume":"30","author":"Prentice","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.229","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01920","article-title":"Update on Transplacental Transfer of IgG Subclasses: Impact of Maternal and Fetal Factors","volume":"11","author":"Clements","year":"2020","journal-title":"Front Immunol"},{"key":"2026060303500874000_75.2.208.230","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/apt.14040","article-title":"The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease","volume":"45","author":"Seow","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060303500874000_75.2.208.231","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/ibd\/izab206","article-title":"Risk Factors for Postpartum Disease Activity in Women With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","volume":"28","author":"Malhi","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.232","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.08.055"},{"key":"2026060303500874000_75.2.208.233","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0176-7"},{"key":"2026060303500874000_75.2.208.234","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cgh.2023.08.039","article-title":"Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis","volume":"22","author":"Katibian","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.235","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S2468-1253(22)00385-5","article-title":"GETAID and the SPARE-Biocycle research group. Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn\u2019s disease on combination therapy","volume":"8","author":"Louis","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.236","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cgh.2020.09.021","article-title":"Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis","volume":"20","author":"Nielsen","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.237","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ibd\/izz110","article-title":"Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes","volume":"26","author":"Julsgaard","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.238","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309321"},{"key":"2026060303500874000_75.2.208.239","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001234"},{"key":"2026060303500874000_75.2.208.240","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.7326\/M22-0819","article-title":"Benefits and Risks Associated With Continuation of Anti-Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease : A Nationwide Emulation Trial","volume":"175","author":"Meyer","year":"2022","journal-title":"Ann Intern Med"},{"key":"2026060303500874000_75.2.208.241","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/ibd\/izz250","article-title":"Early Discontinuation of Infliximab in Pregnant Women With Inflammatory Bowel Disease","volume":"26","author":"Truta","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.242","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-174"},{"key":"2026060303500874000_75.2.208.243","doi-asserted-by":"crossref","first-page":"102676","DOI":"10.1016\/j.jaut.2021.102676","article-title":"Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-\u03b1 during pregnancy: A systemic review and meta-analysis","volume":"122","author":"Barenbrug","year":"2021","journal-title":"J Autoimmun"},{"key":"2026060303500874000_75.2.208.244","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.501"},{"key":"2026060303500874000_75.2.208.245","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15539"},{"key":"2026060303500874000_75.2.208.246","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.04.002"},{"key":"2026060303500874000_75.2.208.247","doi-asserted-by":"crossref","first-page":"S419","DOI":"10.1093\/ecco-jcc\/jjx180.741","article-title":"P614 Pregnancy outcomes in women with IBD treated with biosimilar infliximab","volume":"12","author":"Kolar","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.248","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(24)03110-X","article-title":"Mo1871 USE OF BIOSIMILARS TO INFLIXIMAB DURING PREGNANCY IN WOMEN WITH INFLAMMATORY BOWEL DISEASE","volume":"166","author":"Long","year":"2024","journal-title":"Gastroenterology"},{"key":"2026060303500874000_75.2.208.249","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1753495X211028779","article-title":"Outcomes following biosimilar TNF inhibitor use for inflammatory-mediated immune disorders in pregnancy","volume":"15","author":"Scott","year":"2022","journal-title":"Obstet Med"},{"key":"2026060303500874000_75.2.208.250","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1111\/jgh.15574","article-title":"Systematic review and meta\u2010analysis: Safety of vedolizumab during pregnancy in patients with inflammatory bowel disease","volume":"36","author":"Bell","year":"2021","journal-title":"J of Gastro and Hepatol"},{"key":"2026060303500874000_75.2.208.251","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002553"},{"key":"2026060303500874000_75.2.208.252","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/apt.16593","article-title":"Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population\u2010based cohort study","volume":"54","author":"Julsgaard","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060303500874000_75.2.208.253","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/ecco-jcc\/jjac086","article-title":"Safety of Ustekinumab and Vedolizumab During Pregnancy\u2014Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study","volume":"16","author":"Mitrova","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.254","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2024.02.025","article-title":"Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero","volume":"23","author":"Prentice","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.255","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cgh.2023.12.029","article-title":"Safety of Vedolizumab and Ustekinumab Compared With Anti-TNF in Pregnant Women With Inflammatory Bowel Disease","volume":"23","author":"Meyer","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.256","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s40262-024-01370-7","article-title":"Pharmacokinetics of Monoclonal Antibodies Throughout Pregnancy: A Systematic Literature Review","volume":"63","author":"van Gendt","year":"2024","journal-title":"Clin Pharmacokinet"},{"key":"2026060303500874000_75.2.208.257","doi-asserted-by":"crossref","DOI":"10.1093\/crocol\/otac025","article-title":"Ustekinumab Exposure in Pregnant Women From Inflammatory Bowel Disease Clinical Trials: Pregnancy Outcomes Through Up To 5 Years in Crohn\u2019s Disease and 2 Years in Ulcerative Colitis","volume":"4","author":"Abraham","year":"2022","journal-title":"Crohn\u2019s & Colitis 360"},{"key":"2026060303500874000_75.2.208.258","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/apt.17224","article-title":"Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study","volume":"56","author":"Avni\u2010Biron","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060303500874000_75.2.208.259","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1111\/bcp.15471","article-title":"Reported congenital malformations after exposure to non\u2010tumour necrosis factor inhibitor biologics: A retrospective comparative study in EudraVigilance","volume":"88","author":"Ghalandari","year":"2022","journal-title":"Brit J Clinical Pharma"},{"key":"2026060303500874000_75.2.208.260","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cgh.2024.01.008","article-title":"Infant Ustekinumab Clearance, Risk of Infection, and Development After Exposure During Pregnancy","volume":"23","author":"Julsgaard","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.261","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/apt.16960","article-title":"Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer\u2019s global safety database","volume":"56","author":"Mahadevan","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060303500874000_75.2.208.262","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/ibd\/izae182","article-title":"Low Placental Transfer Rates of Risankizumab Among Pregnant Women With Inflammatory Bowel Disease","volume":"30","author":"Mahadevan","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.263","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14931","article-title":"Considerations on inhibition of IL-23 in psoriatic women of childbearing potential","volume":"34","author":"Russo","year":"2021","journal-title":"Dermatol Ther"},{"key":"2026060303500874000_75.2.208.264","doi-asserted-by":"crossref","first-page":"295","DOI":"10.18502\/ijrm.v21i4.13269","article-title":"The presence, severity, and onset of preeclampsia is associated with maternal interleukin-23 level: A case-control study","volume":"21","author":"Forghani","year":"2023","journal-title":"Int J Reprod Biomed"},{"key":"2026060303500874000_75.2.208.265","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1997.00660.x"},{"key":"2026060303500874000_75.2.208.266","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/2589977515666221212150311","article-title":"Relationship Between Amoxicillin Use in Pregnancy and Congenital Anomalies: A Systematic Review","volume":"15","author":"Bahri","year":"2023","journal-title":"Curr Drug Res Rev"},{"key":"2026060303500874000_75.2.208.267","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.reprotox.2019.02.002","article-title":"Pregnancy outcomes following quinolone and fluoroquinolone exposure during pregnancy: A systematic review and meta-analysis","volume":"85","author":"Acar","year":"2019","journal-title":"Reprod Toxicol"},{"key":"2026060303500874000_75.2.208.268","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/jcpt.13340","article-title":"Pregnancy outcomes in female patients exposed to cyclosporin-based versus tacrolimus-based immunosuppressive regimens after liver\/kidney transplantation: A systematic review and meta-analysis","volume":"46","author":"Gong","year":"2021","journal-title":"J Clin Pharm Ther"},{"key":"2026060303500874000_75.2.208.269","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1111\/bcp.15414","article-title":"Pregnancy and neonatal outcomes in women receiving calcineurin inhibitors: A systematic review and meta-analysis","volume":"88","author":"Akiyama","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"2026060303500874000_75.2.208.270","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20858"},{"key":"2026060303500874000_75.2.208.271","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/ibd\/izaa109","article-title":"Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature","volume":"26","author":"Rosen","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.272","doi-asserted-by":"crossref","first-page":"bcr","DOI":"10.1136\/bcr-2017-223540","article-title":"Salvage therapy for acute severe ulcerative colitis during pregnancy","volume":"2018","author":"Raval","year":"2018","journal-title":"BMJ Case Rep"},{"key":"2026060303500874000_75.2.208.273","article-title":"Cyclosporine treatment of severe ulcerative colitis during pregnancy","volume":"90","author":"Bertschinger","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"2026060303500874000_75.2.208.274","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1136\/gut.2005.078972","article-title":"Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis","volume":"54","author":"Baumgart","year":"2005","journal-title":"Gut"},{"key":"2026060303500874000_75.2.208.275","first-page":"1364","article-title":"Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancy","volume":"55","author":"Angelberger","year":"2006","journal-title":"Gut"},{"key":"2026060303500874000_75.2.208.276","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1093\/ibd\/izae011","article-title":"Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn\u2019s Disease, and Relapsing Multiple Sclerosis","volume":"30","author":"Dubinsky","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.277","doi-asserted-by":"crossref","DOI":"10.14309\/01.ajg.0001035116.14492.4e","article-title":"S1437\u2003Pregnancy Outcomes in the Etrasimod Clinical Program","volume":"119","author":"Gecse","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"2026060303500874000_75.2.208.278","unstructured":"Xeljanz (Tofacitinib). Available: https:\/\/labeling.pfizer.com\/showlabeling.aspx?id=959 [Accessed 2 Sep 2024]."},{"key":"2026060303500874000_75.2.208.279","unstructured":"Jyseleca (Filgotinib). Available: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/jyseleca#product-info [Accessed 2 Sep 2024]."},{"key":"2026060303500874000_75.2.208.280","unstructured":"Rinvoq (Upadacitinib). Available: https:\/\/www.rxabbvie.com\/pdf\/rinvoq_pi.pdf [Accessed 2 Sep 2024]."},{"key":"2026060303500874000_75.2.208.281","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13010034","article-title":"Reproductive Safety Issues of Novel Small Molecules for the Treatment of Inflammatory Bowel Disease: A Systematic Review","volume":"13","author":"Monfared","year":"2023","journal-title":"J Clin Med"},{"key":"2026060303500874000_75.2.208.282","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(24)00885-0","article-title":"716 PREGNANCY OUTCOMES AFTER MATERNAL OR PATERNAL EXPOSURE IN THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAM","volume":"166","author":"Mahadevan","year":"2024","journal-title":"Gastroenterology"},{"key":"2026060303500874000_75.2.208.283","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s40264-024-01454-0","article-title":"Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing Reports","volume":"47","author":"Mahadevan","year":"2024","journal-title":"Drug Saf"},{"key":"2026060303500874000_75.2.208.284","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200211000-00003"},{"key":"2026060303500874000_75.2.208.285","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.03.017"},{"key":"2026060303500874000_75.2.208.286","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/ajcn\/82.2.486","article-title":"Breastfeeding and risk of inflammatory bowel disease","volume":"82","author":"Klement","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"2026060303500874000_75.2.208.287","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14291"},{"key":"2026060303500874000_75.2.208.288","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00526.x"},{"key":"2026060303500874000_75.2.208.289","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1440-1746.2009.06140.x","article-title":"Population\u2010based cases control study of inflammatory bowel disease risk factors","volume":"25","author":"Gearry","year":"2010","journal-title":"J of Gastro and Hepatol"},{"key":"2026060303500874000_75.2.208.290","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-3624"},{"key":"2026060303500874000_75.2.208.291","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S2468-1253(22)00021-8","article-title":"Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus","volume":"7","author":"Ananthakrishnan","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.292","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00758-3"},{"key":"2026060303500874000_75.2.208.293","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i6.743"},{"key":"2026060303500874000_75.2.208.294","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20206"},{"key":"2026060303500874000_75.2.208.295","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.054353"},{"key":"2026060303500874000_75.2.208.296","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(17)32637-9","article-title":"Maternal IBD and IBD Therapies may Influence Breast Milk Pro-Inflammatory Cytokines and the Infant\u2019s Fecal Calprotectin","volume":"152","author":"Agrawal","year":"2017","journal-title":"Gastroenterology"},{"key":"2026060303500874000_75.2.208.297","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy186"},{"key":"2026060303500874000_75.2.208.298","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad096"},{"key":"2026060303500874000_75.2.208.299","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/ibd\/izz313","article-title":"Incidence and Predictors of Flares in the Postpartum Year Among Women With Inflammatory Bowel Disease","volume":"26","author":"Yu","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.300","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.362"},{"key":"2026060303500874000_75.2.208.301","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.40785.x"},{"key":"2026060303500874000_75.2.208.302","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3109\/00365521.2014.920913","article-title":"Self-reported adherence to medical treatment, breastfeeding behaviour, and disease activity during the postpartum period in women with Crohn\u2019s disease","volume":"49","author":"Julsgaard","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"2026060303500874000_75.2.208.303","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1089\/bfm.2018.0111","article-title":"Determination of Mesalamine levels in Human Milk as a Function of Dose","volume":"14","author":"Datta","year":"2019","journal-title":"Breastfeed Med"},{"key":"2026060303500874000_75.2.208.304","unstructured":"Moretti M . Prospective follow-up of infants exposed to 5-aminosalicylic acid containing drugs through maternal milk. University of Toronto, 1998."},{"key":"2026060303500874000_75.2.208.305","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(11)90771-6"},{"key":"2026060303500874000_75.2.208.306","first-page":"5525","article-title":"Inflammatory bowel disease in pregnancy: a report of 7 cases and review of the literature","volume":"10","author":"Xu","year":"2017","journal-title":"Int J Clin Exp Med"},{"key":"2026060303500874000_75.2.208.307","unstructured":"Drugs and lactation database (Lactmed). Available: www.ncbi.nlm.nih.gov\/books\/NBK501922\/ [Accessed 27 May 2025]."},{"key":"2026060303500874000_75.2.208.308","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-198605020-00028"},{"key":"2026060303500874000_75.2.208.309","doi-asserted-by":"publisher","DOI":"10.3109\/00365528109181027"},{"key":"2026060303500874000_75.2.208.310","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03843.x"},{"key":"2026060303500874000_75.2.208.311","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2006.01232.x"},{"key":"2026060303500874000_75.2.208.312","first-page":"62","article-title":"Prospective clinical and biological follow-up of three breastfed babies from azathioprine-treated mothers","volume":"21","author":"Bernard","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"key":"2026060303500874000_75.2.208.313","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.10.005"},{"key":"2026060303500874000_75.2.208.314","unstructured":"Bernard N , Gouraud A , Paret N , et al . Azathioprine and breastfeeding: long-term follow-up. Fundam Clin Pharmacol 2013;27."},{"key":"2026060303500874000_75.2.208.315","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12334"},{"key":"2026060303500874000_75.2.208.316","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2018.05.040","article-title":"Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development","volume":"155","author":"Matro","year":"2018","journal-title":"Gastroenterology"},{"key":"2026060303500874000_75.2.208.317","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-4899-2638-8_32","article-title":"Allopurinol in breast milk","volume":"309A","author":"Kamilli","year":"1991","journal-title":"Adv Exp Med Biol"},{"key":"2026060303500874000_75.2.208.318","first-page":"128","article-title":"National audit: assessing the use and safety of allopurinol thiopurine co-therapy in pregnant females with inflammatory bowel disease","volume":"31","author":"Beswick","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.319","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140263"},{"key":"2026060303500874000_75.2.208.320","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1089\/bfm.2018.0078","article-title":"High-Dose Methotrexate Treatment in a Breastfeeding Mother with Placenta Accreta: A Case Report","volume":"13","author":"Baker","year":"2018","journal-title":"Breastfeed Med"},{"key":"2026060303500874000_75.2.208.321","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(85)80259-6"},{"key":"2026060303500874000_75.2.208.322","first-page":"264","article-title":"Excretion of prednisone and prednisolone in human milk","volume":"21","author":"Berlin","year":"1979","journal-title":"Pharmacologist"},{"key":"2026060303500874000_75.2.208.323","unstructured":"Schaefer C , Peters P , Miller RK , eds. Drugs during Pregnancy and Lactation: Treatment Options and Risk Assessment. Academic Press, 2015."},{"key":"2026060303500874000_75.2.208.324","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bpobgyn.2014.09.001","article-title":"Breast-feeding after transplantation","volume":"28","author":"Constantinescu","year":"2014","journal-title":"Best Practice & Research Clinical Obstetrics & Gynaecology"},{"key":"2026060303500874000_75.2.208.325","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000769","article-title":"Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases","volume":"7","author":"LaHue","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026060303500874000_75.2.208.326","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fnut.2020.00130","article-title":"Partial Degradation of Recombinant Antibody Functional Activity During Infant Gastrointestinal Digestion: Implications for Oral Antibody Supplementation","volume":"7","author":"Sah","year":"2020","journal-title":"Front Nutr"},{"key":"2026060303500874000_75.2.208.327","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/nu12030621","article-title":"Survival of Recombinant Monoclonal Antibodies (IgG, IgA and sIgA) Versus Naturally-Occurring Antibodies (IgG and sIgA\/IgA) in an Ex Vivo Infant Digestion Model","volume":"12","author":"Lueangsakulthai","year":"2020","journal-title":"Nutrients"},{"key":"2026060303500874000_75.2.208.328","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2020.104115"},{"key":"2026060303500874000_75.2.208.329","doi-asserted-by":"crossref","DOI":"10.3390\/nu12071904","article-title":"Binding and Neutralizing Capacity of Respiratory Syncytial Virus (RSV)-Specific Recombinant IgG Against RSV in Human Milk, Gastric and Intestinal Fluids from Infants","volume":"12","author":"Demers-Mathieu","year":"2020","journal-title":"Nutrients"},{"key":"2026060303500874000_75.2.208.330","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112248"},{"key":"2026060303500874000_75.2.208.331","unstructured":"Velsipity (etrasimod). Available: www.ema.europa.eu\/en\/medicines\/human\/EPAR\/velsipity [Accessed 9 Apr 2024]."},{"key":"2026060303500874000_75.2.208.332","unstructured":"Zeposia (ozanimod). Available: www.ema.europa.eu\/en\/medicines\/human\/EPAR\/zeposia [Accessed 4 Mar 2024]."},{"key":"2026060303500874000_75.2.208.333","unstructured":"Velsipity (etrasimod). Available: https:\/\/www.velsipity.com\/ [Accessed 9 Apr 2024]."},{"key":"2026060303500874000_75.2.208.334","unstructured":"Zeposia (ozanimod). Available: https:\/\/www.zeposia.com\/ [Accessed 4 Mar 2024]."},{"key":"2026060303500874000_75.2.208.335","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cgh.2024.01.019","article-title":"Tofacitinib in Pregnancy: Assessing Pregnancy and Infant Outcomes, Cord Blood, and Breast Milk Concentrations","volume":"23","author":"Mitrova","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.336","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S2468-1253(23)00158-9","article-title":"Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis","volume":"8","author":"Julsgaard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.337","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.09.003"},{"key":"2026060303500874000_75.2.208.338","doi-asserted-by":"crossref","unstructured":"Astrup-Jensen A , Bates CJ , Begg EJ , et al . Drugs and human lactation: a comprehensive guide to the content and consequences of drugs, micronutrients, radiopharmaceuticals, and environmental and occupational chemicals in human milk. Elsevier Science Limited, 1996.","DOI":"10.1016\/B978-044481981-9\/50028-X"},{"key":"2026060303500874000_75.2.208.339","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.gastro.2017.08.067","article-title":"Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease","volume":"154","author":"Julsgaard","year":"2018","journal-title":"Gastroenterology"},{"key":"2026060303500874000_75.2.208.340","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.07.007"},{"key":"2026060303500874000_75.2.208.341","doi-asserted-by":"crossref","DOI":"10.1093\/crocol\/otae006","article-title":"Normal Infant Immunologic Assessment and Uneventful Live Rotavirus Vaccination Despite Continuous Tofacitinib Exposure In Utero and During Breastfeeding","volume":"6","author":"Ernest-Suarez","year":"2024","journal-title":"Crohn\u2019s & Colitis 360"},{"key":"2026060303500874000_75.2.208.342","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/bcpt.13098","article-title":"Antibiotics and lactation: An overview of relative infant doses and a systematic assessment of clinical studies","volume":"124","author":"van Wattum","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2026060303500874000_75.2.208.343","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2125.1988.tb03362.x","article-title":"Metronidazole excretion in human milk and its effect on the suckling neonate","volume":"26","author":"Passmore","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"2026060303500874000_75.2.208.344","first-page":"48","article-title":"Metronidazole in breast milk","volume":"57","author":"Erickson","year":"1981","journal-title":"Obstet Gynecol"},{"key":"2026060303500874000_75.2.208.345","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90021-1"},{"key":"2026060303500874000_75.2.208.346","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF02480048","article-title":"Intravenous midazolam passage into breast milk","volume":"11","author":"Koitabashi","year":"1997","journal-title":"J Anesth"},{"key":"2026060303500874000_75.2.208.347","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.clpt.2006.02.010","article-title":"Pharmacokinetics of midazolam, propofol, and fentanyl transfer to human breast milk","volume":"79","author":"Nitsun","year":"2006","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"2026060303500874000_75.2.208.348","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.108324"},{"key":"2026060303500874000_75.2.208.349","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04794.x"},{"key":"2026060303500874000_75.2.208.350","first-page":"1091","article-title":"Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure","volume":"20","author":"Br\u00f6ms","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.351","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/1471-0528.13946","article-title":"Inflammatory bowel disease in pregnancy: a population-based study of prevalence and pregnancy outcomes","volume":"123","author":"Shand","year":"2016","journal-title":"BJOG"},{"key":"2026060303500874000_75.2.208.352","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/MIB.0000000000000802","article-title":"Adverse Pregnancy Outcomes Among Women with Inflammatory Bowel Disease: A Population-Based Study from England","volume":"22","author":"Abdul Sultan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.353","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3037128","article-title":"Regional Variation in Pregnancy Outcomes amongst Women in Inflammatory Bowel Disease: A Population-Based Cohort Study","volume":"2021","author":"Tandon","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.354","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/1471-0528.17039","article-title":"Outcomes during delivery hospitalisations with inflammatory bowel disease","volume":"129","author":"Yu","year":"2022","journal-title":"BJOG"},{"key":"2026060303500874000_75.2.208.355","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101722","article-title":"Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes: A nationwide study","volume":"53","author":"M\u00e5rild","year":"2022","journal-title":"EClinicalMedicine"},{"key":"2026060303500874000_75.2.208.356","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003603","article-title":"Risk of miscarriage in women with chronic diseases in Norway: A registry linkage study","volume":"18","author":"Magnus","year":"2021","journal-title":"PLoS Med"},{"key":"2026060303500874000_75.2.208.357","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158017","article-title":"Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort","volume":"11","author":"Waljee","year":"2016","journal-title":"PLoS One"},{"key":"2026060303500874000_75.2.208.358","doi-asserted-by":"crossref","unstructured":"Kim YH , Pfaller B , Marson A , et al . n.d. The risk of venous thromboembolism in women with inflammatory bowel disease during pregnancy and the postpartum period. Medicine (Abingdon) 98:e17309. doi:10.1097\/MD.0000000000017309","DOI":"10.1097\/MD.0000000000017309"},{"key":"2026060303500874000_75.2.208.359","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/bdra.23509","article-title":"Use of azathioprine and corticosteroids during pregnancy and birth outcome in women diagnosed with inflammatory bowel disease","volume":"106","author":"Plauborg","year":"2016","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2026060303500874000_75.2.208.360","unstructured":"Bryant AS , Miller RS . Pharmacologic stepwise multimodal approach for postpartum pain management. Am Coll Obstet Gynecol 2021."},{"key":"2026060303500874000_75.2.208.361","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2003.08.014"},{"key":"2026060303500874000_75.2.208.362","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02262.x"},{"key":"2026060303500874000_75.2.208.363","doi-asserted-by":"crossref","first-page":"101238","DOI":"10.1016\/j.ajogmf.2023.101238","article-title":"Ketorolac for postpartum pain management in patients with inflammatory bowel disease","volume":"6","author":"Johnson","year":"2024","journal-title":"American Journal of Obstetrics & Gynecology MFM"},{"key":"2026060303500874000_75.2.208.364","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-3677-x"},{"key":"2026060303500874000_75.2.208.365","doi-asserted-by":"crossref","first-page":"1121406","DOI":"10.3389\/fped.2023.1121406","article-title":"Risk factors for length of NICU stay of newborns: A systematic review","volume":"11","author":"Fu","year":"2023","journal-title":"Front Pediatr"},{"key":"2026060303500874000_75.2.208.366","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.430"},{"key":"2026060303500874000_75.2.208.367","doi-asserted-by":"crossref","first-page":"491","DOI":"10.14309\/ajg.0000000000002179","article-title":"Maternal Inflammatory Bowel Disease During Pregnancy and Infectious Disease in Offspring Younger Than 5 Years: A Population-Based Cohort Study","volume":"118","author":"Ren","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"2026060303500874000_75.2.208.368","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01355.x"},{"key":"2026060303500874000_75.2.208.369","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04754.x"},{"key":"2026060303500874000_75.2.208.370","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa225"},{"key":"2026060303500874000_75.2.208.371","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.cgh.2022.08.028","article-title":"Maternal Exposure to Anti-TNF or Thiopurines for IBD Does Not Increase Risk of Early-life Malignancy in Children","volume":"21","author":"Meyer","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.372","unstructured":"Squires J , Twombley E , Bricker D , et al . ASQ-3 user\u2019s guide. Paul H Brookes Publishing Co, 2009."},{"key":"2026060303500874000_75.2.208.373","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/apt.15956","article-title":"In utero exposure to thiopurines\/anti-TNF agents and long-term health outcomes during childhood and adolescence in Denmark","volume":"52","author":"N\u00f8rg\u00e5rd","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060303500874000_75.2.208.374","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/CEG.S59360","article-title":"Autism spectrum disorders in children of parents with inflammatory bowel disease \u2013 a nationwide cohort study in Denmark","volume":"7","author":"Andersen","year":"2014","journal-title":"CEG"},{"key":"2026060303500874000_75.2.208.375","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/ecco-jcc\/jjaa106","article-title":"Long-term Motor and Cognitive Function in the Children of Women With Inflammatory Bowel Disease","volume":"14","author":"Friedman","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.376","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2021.12.159","article-title":"Long term adverse health outcomes in offspring from mothers with inflammatory bowel disease: a nationwide population based study in Korea","volume":"162","author":"Ahn","year":"2022","journal-title":"Gastroenterology"},{"key":"2026060303500874000_75.2.208.377","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/ecco-jcc\/jjw083","article-title":"Maternal Inflammatory Bowel Disease During Pregnancy is Not a Risk Factor for Long-term Morbidity of the Offspring","volume":"10","author":"Freud","year":"2016","journal-title":"ECCOJC"},{"key":"2026060303500874000_75.2.208.378","doi-asserted-by":"crossref","DOI":"10.1038\/s41424-018-0018-3","article-title":"Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants","volume":"9","author":"Kattah","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"2026060303500874000_75.2.208.379","doi-asserted-by":"crossref","first-page":"935034","DOI":"10.3389\/fped.2022.935034","article-title":"Immune function in newborns with in-utero exposure to anti-TNF\u03b1 therapy","volume":"10","author":"Weiss","year":"2022","journal-title":"Front Pediatr"},{"key":"2026060303500874000_75.2.208.380","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cgh.2017.08.041","article-title":"Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines","volume":"16","author":"Beaulieu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026060303500874000_75.2.208.381","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ecco-jcc\/jjy053","article-title":"Hepatitis B Vaccination Effective in Children Exposed to Anti-Tumour Necrosis Factor Alpha in Utero","volume":"12","author":"de Lima","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.382","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5217\/ir.2018.00071","article-title":"Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children\u2019s immunity","volume":"17","author":"Lee","year":"2019","journal-title":"Intest Res"},{"key":"2026060303500874000_75.2.208.383","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/ibd\/izy294","article-title":"Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation","volume":"25","author":"Duricova","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2026060303500874000_75.2.208.384","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.vaccine.2022.03.041","article-title":"Efficacy, immunogenicity, and safety of available vaccines in children on biologics: A systematic review and meta-analysis","volume":"40","author":"Gertosio","year":"2022","journal-title":"Vaccine (Auckl)"},{"key":"2026060303500874000_75.2.208.385","doi-asserted-by":"crossref","first-page":"i874","DOI":"10.1093\/ecco-jcc\/jjac190.0874","article-title":"P744 Safety of live vaccines in children exposed to biological agents for inflammatory bowel disease (IBD) in utero or during breastfeeding","volume":"17","author":"Chaparro","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.386","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1093\/rheumatology\/keac141","article-title":"A systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic drugs in utero","volume":"61","author":"Goulden","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026060303500874000_75.2.208.387","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S2352-4642(23)00136-0","article-title":"Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network","volume":"7","author":"Fitzpatrick","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"2026060303500874000_75.2.208.388","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.05.001"},{"key":"2026060303500874000_75.2.208.389","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000440984.86659.4f"},{"key":"2026060303500874000_75.2.208.390","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/ecco-jcc\/jjaa099","article-title":"Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease","volume":"14","author":"Park","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2026060303500874000_75.2.208.391","unstructured":"Medicines and healthcare products regulatory agency UK. Available: https:\/\/www.gov.uk\/drug-safety-update\/live-attenuated-vaccines-avoid-use-in-those-who-are-clinically-immunosuppressed#fatal-bcg-infection-in-neonates-after-in-utero-exposure-to-tnf-antagonist [Accessed 27 Mar 2024]."},{"key":"2026060303500874000_75.2.208.392","unstructured":"Remicade\/flixabi\/inflectra\/remsima\/zessly - direct healthcare professional communication (DHPC). Available: www.ema.europa.eu\/en\/documents\/dhpc\/direct-healthcare-professional-communication-dhpc-infliximab-remicade-flixabi-inflectra-remsima-and-zessly-use-live-vaccines-infants-exposed-utero-or-during-breastfeeding_en.pdf [Accessed 27 May 2025]."},{"key":"2026060303500874000_75.2.208.393","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31825f2807"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2025-336402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:00:15Z","timestamp":1780581615000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2025-336402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":393,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1,8]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/gutjnl-2025-336402"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2025-336402","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]}}}